The identification of the high-risk human papilloma viruses (HPVs) as a cause of cervical cancer offered the possibility for the development of a HPV vaccine. Twenty years after this identification of the HPV types, the first HPV vaccine came to the market. There are three HPV vaccines today on the market, all containing the virus-like particles (VLPs) of the HPV types 16 and 18, which are considered to cause 77 % of all cancers caused by HPVs. In addition, two of the vaccines contain two low-risk HPV types (6 and 11)-quadrivalent or the same as low-risk types and additional high-risk HPV types (31, 32, 45, 52, 58)-nonavalent vaccines. The cervical cancer protection efficacy of the vaccines is very high, around 100%. The VLPs of the 6- and 11-type offer efficient protection against genital warts. Unfortunately, the implementation of the vaccination is actually not so high despite all scientific and medical facts, but their rates in Europe are steadily increasing reaching about 90% in one country after another. In Serbia, all of the three vaccines are on the market but are highly underused. Actually, there is no national program and the Serbian vaccination rates are very low. High vaccination rates in Serbia need to be achieved as a goal of prevention of cervical cancer.
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
3
Omid Gholizadeh, Zahra Yekanipour, Setareh Kivi, Farnoosh Farahbod, Mohadeseh Aqayinejad, Yalda Tasoujizade, Saman Yasamineh, Parya Amini, Sama Akbarzadeh, Mehrnaz Hajiesmaeili, Vahdat Poortahmasebi
(2023)
Review of the evidence of the effects of human papillomavirus infection and Gardnerella vaginalis, and their co-infection on infertility
Microbial Pathogenesis, 175()
10.1016/j.micpath.2023.105980
Samaneh Jouya, Nahid Golmakani
(2020)
The effect of transcutaneous auricular stimulation on anxiety before colposcopy: A randomized clinical trial
AFMN Biomedicine, 37(4)
10.5937/afmnai2004405j
B. Sai Lalitha, Mudigonda Malini, M. Venkateswar Rao, Mahendran Botlagunta
(2023)
Proceedings of the Second International Conference on Emerging Trends in Engineering (ICETE 2023)
Advances in Engineering Research, 223()
10.2991/978-94-6463-252-1_18The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.